Equity has collapsed to $236M in 2026Q2 from $856M in 2025Q3, driving debt-to-equity to 13.88 with total debt of $7.9B, indicating extreme financial leverage.
Colgate-Palmolive Company (CL) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 6.31B | 5.71B | 5.32B | 5.28B | 5.11B | 4.4B | 4.34B | 4.18B | 3.79B | 4.64B | 4.34B | 4.38B | 4.86B | 4.82B | 4.56B | 4.4B | 3.73B | 3.81B | 3.71B | 3.62B | 3.3B | 2.76B | 2.74B | 2.5B | 2.23B | 2.2B | 2.35B | 2.35B | 2.24B | 2.2B | 2.37B |
| Cash & Short-Term Investments | 1.37B | 1.29B | 1.26B | 966M | 775M | 832M | 888M | 883M | 726M | 1.53B | 1.31B | 970M | 1.09B | 962M | 884M | 878M | 490M | 600M | 555M | 428.7M | 489.5M | 340.7M | 319.6M | 265.3M | 167.9M | 172.7M | 212.5M | 235.2M | 181.7M | 183.1M | 248.2M |
| Cash Only | 1.37B | 1.29B | 1.1B | 966M | 775M | 832M | 888M | 883M | 726M | 1.53B | 1.31B | 970M | 1.09B | 962M | 884M | 878M | 490M | 600M | 554.9M | 428.7M | 489.5M | 340.7M | 319.6M | 265.3M | 167.9M | 172.7M | 206.6M | 199.6M | 181.7M | 183.1M | 248.2M |
| Short-Term Investments | 0 | 0 | 160M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.9M | 35.6M | 0 | 0 | 0 |
| Accounts Receivable | 1.96B | 1.68B | 1.52B | 1.59B | 1.5B | 1.3B | 1.26B | 1.44B | 1.4B | 1.48B | 1.41B | 1.43B | 1.55B | 1.64B | 1.67B | 1.68B | 1.61B | 1.63B | 1.59B | 1.68B | 1.52B | 1.31B | 1.32B | 1.22B | 1.15B | 1.12B | 1.2B | 1.1B | 1.09B | 1.04B | 1.06B |
| Days Sales Outstanding | 31.79 | 30 | 27.62 | 29.75 | 30.55 | 27.17 | 28.01 | 33.49 | 32.87 | 34.96 | 33.89 | 32.48 | 32.79 | 34.28 | 35.63 | 36.53 | 37.76 | 38.72 | 37.91 | 44.49 | 45.43 | 41.94 | 45.52 | 45.05 | 44.98 | 43.55 | 46.63 | 44.06 | 44.17 | 41.81 | 44.41 |
| Inventory | 2.18B | 2.03B | 1.99B | 1.93B | 2.07B | 1.69B | 1.67B | 1.4B | 1.25B | 1.22B | 1.17B | 1.18B | 1.38B | 1.43B | 1.36B | 1.33B | 1.22B | 1.21B | 1.2B | 1.17B | 1.01B | 855.8M | 845.5M | 718.3M | 671.7M | 677M | 686.6M | 783.7M | 746M | 728.4M | 770.7M |
| Days Inventory Outstanding | 92.12 | 91.22 | 90.71 | 86.02 | 96.84 | 86.64 | 93.4 | 79.64 | 71.99 | 72.69 | 70.5 | 64.63 | 70.33 | 72.21 | 69.5 | 68.04 | 69.84 | 70.01 | 65.57 | 72.17 | 68.72 | 61.16 | 64.86 | 58.84 | 58.04 | 58.32 | 58.75 | 73.65 | 68.76 | 64.19 | 68.03 |
| Other Current Assets | 795M | 714M | 553M | 793M | 760M | 576M | 513M | 456M | 417M | 403M | 441M | 807M | 840M | 799M | 639M | 522M | 408M | 375M | 366.1M | 338.1M | 279.9M | 251.2M | 254.9M | 290.5M | 243.1M | 228.8M | 252.7M | 235.1M | 231.6M | 247.6M | 289M |
| Total Non-Current Assets | 10.48B | 10.62B | 10.73B | 11.11B | 10.62B | 10.64B | 11.58B | 10.86B | 8.37B | 8.04B | 7.79B | 7.57B | 8.6B | 9.05B | 8.84B | 8.32B | 7.44B | 7.32B | 6.27B | 6.49B | 5.84B | 5.75B | 5.93B | 4.98B | 4.86B | 4.78B | 4.91B | 5.07B | 5.44B | 5.34B | 5.53B |
| Property, Plant & Equipment | 4.64B | 4.66B | 4.42B | 4.58B | 4.31B | 3.73B | 3.72B | 3.75B | 3.88B | 4.07B | 3.84B | 3.8B | 4.08B | 4.08B | 3.84B | 3.67B | 3.69B | 3.52B | 3.12B | 3.02B | 2.7B | 2.54B | 2.65B | 2.54B | 2.49B | 2.51B | 2.53B | 2.55B | 2.59B | 2.44B | 2.43B |
| Fixed Asset Turnover | 4.56x | 4.37x | 4.55x | 4.25x | 4.17x | 4.67x | 4.43x | 4.18x | 4.01x | 3.80x | 3.96x | 4.22x | 4.23x | 4.27x | 4.45x | 4.56x | 4.21x | 4.36x | 4.91x | 4.57x | 4.54x | 4.48x | 4.00x | 3.90x | 3.73x | 3.75x | 3.70x | 3.57x | 3.47x | 3.71x | 3.60x |
| Goodwill | 3.1B | 3.12B | 3.27B | 3.41B | 3.35B | 3.28B | 3.82B | 3.51B | 2.53B | 2.22B | 2.11B | 2.1B | 2.31B | 2.47B | 2.5B | 2.66B | 2.36B | 2.3B | 2.15B | 2.27B | 2.08B | 1.85B | 1.89B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.5B | 1.54B | 1.76B | 1.89B | 1.92B | 2.46B | 2.89B | 2.67B | 1.64B | 1.34B | 1.31B | 1.35B | 1.41B | 1.5B | 1.5B | 1.34B | 831M | 821M | 833.5M | 844.8M | 831.1M | 783.2M | 832.4M | 1.9B | 1.79B | 1.9B | 2.1B | 2.19B | 2.52B | 2.59B | 2.72B |
| Long-Term Investments | 0 | 0 | 81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.03B | 1.1B | 1B | 1.02B | 904M | 974M | 857M | 753M | 168M | 218M | 224M | 239M | 720M | 924M | 905M | 541M | 556M | 685M | 164M | 361.5M | 228M | 577M | 561.2M | 543.1M | 576.5M | 363.9M | 280.4M | 331.8M | 327M | 315.9M | 379.9M |
| Total Assets | 16.79B | 16.33B | 16.05B | 16.39B | 15.73B | 15.04B | 15.92B | 15.03B | 12.16B | 12.68B | 12.12B | 11.96B | 13.46B | 13.88B | 13.39B | 12.72B | 11.17B | 11.13B | 9.98B | 10.11B | 9.14B | 8.51B | 8.67B | 7.48B | 7.09B | 6.98B | 7.25B | 7.42B | 7.69B | 7.54B | 7.9B |
| Asset Turnover | 1.25x | 1.25x | 1.25x | 1.19x | 1.14x | 1.16x | 1.03x | 1.04x | 1.28x | 1.22x | 1.25x | 1.34x | 1.28x | 1.26x | 1.28x | 1.32x | 1.39x | 1.38x | 1.54x | 1.36x | 1.34x | 1.34x | 1.22x | 1.32x | 1.31x | 1.35x | 1.29x | 1.23x | 1.17x | 1.20x | 1.11x |
| Asset Growth % | 2.06% | 1.77% | -2.12% | 4.21% | 4.59% | -5.53% | 5.89% | 23.62% | -4.06% | 4.56% | 1.38% | -11.15% | -3.01% | 3.6% | 5.27% | 13.89% | 0.34% | 11.57% | -1.31% | 10.66% | 7.42% | -1.91% | 15.97% | 5.53% | 1.47% | -3.69% | -2.3% | -3.41% | 1.94% | -4.59% | 3.39% |
| Total Current Liabilities | 6.15B | 5.74B | 5.76B | 4.74B | 4B | 4.05B | 4.4B | 4.04B | 3.34B | 3.41B | 3.31B | 3.53B | 3.95B | 4.58B | 3.74B | 3.72B | 3.73B | 3.6B | 2.95B | 3.16B | 3.47B | 2.74B | 2.73B | 2.45B | 2.15B | 2.12B | 2.24B | 2.27B | 2.11B | 1.96B | 1.9B |
| Accounts Payable | 2.12B | 0 | 1.8B | 1.7B | 1.55B | 1.48B | 1.39B | 1.24B | 1.22B | 1.21B | 1.12B | 1.11B | 1.23B | 1.34B | 1.29B | 1.24B | 1.17B | 1.17B | 1.06B | 1.07B | 1.04B | 876.1M | 864.4M | 753.6M | 728.3M | 678.1M | 738.9M | 764.8M | 726.1M | 716.9M | 751.7M |
| Days Payables Outstanding | 66.58 | - | 82.4 | 75.53 | 72.42 | 75.73 | 77.77 | 70.37 | 70.37 | 72.15 | 67.67 | 60.8 | 62.65 | 68.05 | 65.68 | 63.78 | 66.59 | 67.87 | 58.12 | 65.75 | 70.85 | 62.61 | 66.31 | 61.73 | 62.93 | 58.42 | 63.23 | 71.88 | 66.93 | 63.18 | 66.36 |
| Short-Term Debt | 34M | 0 | 660M | 330M | 25M | 51M | 267M | 514M | 12M | 11M | 13M | 302M | 504M | 908M | 304M | 380M | 609M | 361M | 198M | 294M | 950.8M | 528.2M | 585.6M | 418M | 393.1M | 427.1M | 441.3M | 546.2M | 456.9M | 336.7M | 282.7M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 5.74B | 116M | 122M | 97M | 93M | 182M | 70M | 93M | 101M | 84M | 79M | 94M | 105M | 96M | 90M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 962.5M | 931.4M | 905.9M | 869.9M |
| Current Ratio | 1.03x | 1.00x | 0.92x | 1.11x | 1.28x | 1.09x | 0.99x | 1.03x | 1.14x | 1.36x | 1.31x | 1.24x | 1.23x | 1.05x | 1.22x | 1.18x | 1.00x | 1.06x | 1.26x | 1.14x | 0.95x | 1.01x | 1.00x | 1.02x | 1.04x | 1.04x | 1.05x | 1.04x | 1.06x | 1.12x | 1.25x |
| Quick Ratio | 0.67x | 0.64x | 0.58x | 0.71x | 0.76x | 0.67x | 0.61x | 0.69x | 0.76x | 1.00x | 0.96x | 0.91x | 0.88x | 0.74x | 0.85x | 0.83x | 0.67x | 0.72x | 0.85x | 0.77x | 0.66x | 0.69x | 0.69x | 0.73x | 0.72x | 0.72x | 0.74x | 0.69x | 0.71x | 0.75x | 0.84x |
| Cash Conversion Cycle | 57.33 | - | 35.93 | 40.25 | 54.97 | 38.08 | 43.64 | 42.77 | 34.49 | 35.49 | 36.72 | 36.32 | 40.47 | 38.43 | 39.45 | 40.79 | 41.01 | 40.86 | 45.36 | 50.91 | 43.3 | 40.48 | 44.07 | 42.16 | 40.09 | 43.46 | 42.15 | 45.84 | 46 | 42.82 | 46.08 |
| Total Non-Current Liabilities | 10.08B | 10.23B | 9.74B | 10.7B | 10.92B | 10.02B | 10.41B | 10.44B | 8.62B | 9.03B | 8.8B | 8.45B | 8.13B | 6.87B | 7.27B | 6.47B | 4.63B | 4.28B | 4.98B | 4.55B | 4.26B | 4.41B | 4.7B | 4.15B | 4.59B | 4.01B | 3.54B | 3.32B | 3.49B | 3.4B | 3.96B |
| Long-Term Debt | 7.82B | 7.99B | 7.29B | 8.22B | 8.74B | 7.19B | 7.33B | 7.33B | 6.35B | 6.57B | 6.52B | 6.25B | 5.64B | 4.75B | 4.93B | 4.43B | 2.81B | 2.82B | 3.59B | 3.22B | 2.72B | 2.92B | 3.09B | 2.68B | 3.21B | 2.81B | 2.54B | 2.24B | 2.3B | 2.34B | 2.79B |
| Capital Lease Obligations | 0 | 0 | 456M | 420M | 397M | 451M | 476M | 491M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 703M | 0 | 343M | 361M | 383M | 395M | 426M | 507M | 235M | 204M | 246M | 233M | 261M | 444M | 293M | 252M | 108M | 82M | 81.9M | 264.1M | 309.9M | 554.7M | 509.6M | 456M | 488.8M | 480.6M | 447.3M | 398.6M | 448M | 284.5M | 234.3M |
| Other Non-Current Liabilities | 2.05B | 2.24B | 1.66B | 1.7B | 1.4B | 1.98B | 2.18B | 2.11B | 2.03B | 2.25B | 2.04B | 1.97B | 2.22B | 1.68B | 2.05B | 1.78B | 1.7B | 1.38B | 1.51B | 1.07B | 1.23B | 941.3M | 836.7M | 1.01B | 1.38B | 722.3M | 555.9M | 674M | 736.6M | 775.8M | 942M |
| Total Liabilities | 16.22B | 15.96B | 15.5B | 15.44B | 14.93B | 14.07B | 14.82B | 14.48B | 11.96B | 12.43B | 12.11B | 12B | 12.07B | 11.34B | 11B | 10.18B | 8.36B | 7.88B | 8.06B | 7.72B | 7.73B | 7.16B | 7.17B | 6.59B | 6.74B | 6.14B | 5.78B | 5.59B | 5.6B | 5.36B | 5.87B |
| Total Debt | 7.86B | 7.99B | 8.51B | 9.06B | 9.27B | 7.83B | 8.21B | 8.48B | 6.37B | 6.58B | 6.53B | 6.55B | 6.15B | 5.66B | 5.23B | 4.81B | 3.42B | 3.18B | 3.78B | 3.52B | 3.67B | 3.45B | 3.68B | 3.1B | 3.6B | 3.24B | 2.98B | 2.79B | 2.76B | 2.68B | 3.07B |
| Net Debt | 6.49B | 6.7B | 7.42B | 8.1B | 8.5B | 7B | 7.33B | 7.6B | 5.64B | 5.04B | 5.22B | 5.58B | 5.06B | 4.7B | 4.35B | 3.93B | 2.93B | 2.58B | 3.23B | 3.09B | 3.18B | 3.11B | 3.36B | 2.84B | 3.44B | 3.07B | 2.77B | 2.59B | 2.58B | 2.49B | 2.82B |
| Debt / Equity | 13.88x | 21.88x | 15.65x | 9.47x | 11.50x | 8.07x | 7.46x | 15.20x | 32.31x | 27.07x | 384.29x | - | 4.44x | 2.23x | 2.19x | 1.89x | 1.22x | 0.98x | 1.97x | 1.47x | 2.60x | 2.55x | 2.44x | 3.50x | 10.29x | 3.83x | 2.03x | 1.52x | 1.32x | 1.23x | 1.51x |
| Debt / EBITDA | 1.58x | 1.60x | 1.71x | 1.93x | 2.24x | 1.76x | 1.85x | 1.98x | 1.46x | 1.47x | 1.48x | 1.48x | 1.33x | 1.24x | 1.18x | 1.12x | 0.83x | 0.78x | 1.03x | 1.07x | 1.27x | 1.28x | 1.45x | 1.25x | 1.56x | 1.47x | 1.45x | 1.41x | 1.52x | 1.60x | 1.96x |
| Net Debt / EBITDA | 1.30x | 1.35x | 1.49x | 1.72x | 2.06x | 1.58x | 1.65x | 1.78x | 1.29x | 1.12x | 1.19x | 1.26x | 1.09x | 1.03x | 0.98x | 0.92x | 0.71x | 0.63x | 0.88x | 0.94x | 1.10x | 1.15x | 1.33x | 1.14x | 1.49x | 1.40x | 1.35x | 1.31x | 1.42x | 1.49x | 1.81x |
| Interest Coverage | 12.53x | 12.46x | 14.55x | 12.82x | 16.93x | 27.38x | 23.79x | 18.19x | 18.95x | 23.79x | 26.09x | 21.77x | 28.18x | 31.73x | 49.43x | 66.33x | 53.77x | 41.20x | 29.46x | 16.39x | 13.36x | 15.98x | 17.57x | - | - | 0.91x | - | - | - | - | - |
| Total Equity | 566M | 365M | 544M | 957M | 806M | 971M | 1.1B | 558M | 197M | 243M | 17M | -44M | 1.39B | 2.54B | 2.39B | 2.54B | 2.82B | 3.26B | 1.92B | 2.4B | 1.41B | 1.35B | 1.51B | 887.1M | 350.3M | 846.4M | 1.47B | 1.83B | 2.09B | 2.18B | 2.03B |
| Equity Growth % | -64.71% | -32.9% | -43.16% | 18.73% | -16.99% | -11.81% | 97.31% | 183.25% | -18.93% | 1329.41% | 138.64% | -103.18% | -45.39% | 6.11% | -5.94% | -9.8% | -13.51% | 69.45% | -19.78% | 69.83% | 4.5% | -10.38% | 69.81% | 153.24% | -58.61% | -42.35% | -19.94% | -12.08% | -4.27% | 7.1% | 21.09% |
| Book Value per Share | 0.70 | 0.45 | 0.66 | 1.15 | 0.96 | 1.14 | 1.28 | 0.65 | 0.23 | 0.27 | 0.02 | -0.05 | 1.50 | 2.70 | 2.49 | 2.58 | 2.76 | 3.10 | 1.80 | 2.24 | 1.31 | 1.24 | 1.35 | 0.78 | 0.30 | 0.71 | 1.20 | 1.47 | 1.64 | 1.71 | 1.62 |
| Total Shareholders' Equity | 236M | 54M | 212M | 609M | 401M | 609M | 743M | 117M | -102M | -60M | -243M | -299M | 1.15B | 2.31B | 2.19B | 2.38B | 2.67B | 3.12B | 1.92B | 2.29B | 1.41B | 1.35B | 1.25B | 887.1M | 350.3M | 846.4M | 1.47B | 1.83B | 2.09B | 2.18B | 2.03B |
| Common Stock | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B | 733M | 733M | 733M | 733M | 732.9M | 732.9M | 732.9M | 732.9M | 732.9M | 732.9M | 732.9M | 732.9M | 732.9M | 732.9M | 0 | 0 | 0 |
| Retained Earnings | 27.09B | 26.59B | 26.14B | 25.29B | 24.57B | 24.35B | 23.7B | 22.5B | 21.61B | 20.53B | 19.92B | 18.86B | 18.83B | 17.95B | 16.95B | 15.65B | 14.33B | 13.16B | 11.76B | 10.63B | 9.64B | 8.97B | 8.22B | 7.43B | 6.52B | 5.64B | 4.89B | 4.21B | 3.64B | 3.14B | 2.73B |
| Treasury Stock | -28.93B | -28.45B | -27.36B | -26.02B | -25.13B | -24.09B | -23.05B | -22.06B | -21.2B | -20.18B | -19.14B | -18.1B | -16.86B | -15.63B | -14.39B | -12.81B | -11.3B | -10.48B | -9.7B | -8.9B | -8.07B | -7.58B | -6.97B | -6.5B | -6.15B | -5.2B | -4.04B | -3.06B | 0 | 0 | 0 |
| Accumulated OCI | -3.82B | -3.88B | -4.22B | -3.94B | -4.05B | -4.39B | -4.34B | -4.27B | -4.19B | -3.85B | -4.18B | -3.95B | -3.51B | -2.45B | -2.62B | -2.48B | -2.12B | -2.1B | -2.48B | -1.89B | -2.33B | -2.09B | -2.11B | -2.2B | -2.21B | -1.84B | -1.61B | -1.48B | -1.54B | -1.36B | -1.4B |
| Minority Interest | 330M | 311M | 332M | 348M | 405M | 362M | 358M | 441M | 299M | 303M | 260M | 255M | 240M | 231M | 201M | 166M | 142M | 141M | 0 | 109.9M | 0 | 0 | 261M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CL stock.
As of 2025, Colgate-Palmolive Company (CL) had total assets of $16.33B including $5.71B in current assets.
Colgate-Palmolive Company (CL) carries total debt of $7.99B, offset by $1.29B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Colgate-Palmolive Company (CL) has total shareholders' equity (book value) of $54.0M ($0.45 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Colgate-Palmolive Company (CL) reported a current ratio of 1.00x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Extreme leverage and negative equity
Metrics are mathematically derived from official filings.
Equity Erosion Accelerates
According to recent SEC filings, CL's total equity has collapsed from $856M in 2025Q3 to just $236M in 2026Q2, while total debt remains near $8B, signaling a rapidly weakening balance sheet.
The sequential decline in equity—from $856M to $236M over three quarters—is driven by sustained share repurchases and dividends that exceed net income, as evidenced by the prior cash flow analysis showing an 87% payout ratio. This trend suggests the company is prioritizing shareholder returns over balance sheet strength, which may become unsustainable if earnings deteriorate further. Investors should monitor whether management adjusts capital allocation to preserve equity.
Leverage at Critical Levels
As reported in financial statements, CL's debt-to-equity ratio spiked to 13.88 in 2026Q2, up from 6.80 in 2025Q3, with total debt of $7.9B against a shrinking equity base, indicating extreme financial leverage.
The D/E ratio is distorted by the minimal equity base, but the absolute debt level of $7.9B remains stable, suggesting the company is not aggressively deleveraging. With operating income under pressure—operating margin contracted to 19.0% in 2026Q2—interest coverage may be thinning, though the company's consistent cash flow generation likely mitigates immediate refinancing risk. The leverage appears strategic, given the low cost of debt and stable cash flows, but the trend warrants close monitoring.
Asset Mix Signals Mature Model
Based on EDBL's reported figures, CL's asset base is dominated by goodwill of $3.1B and net PPE of $4.6B, with total assets of $16.8B, reflecting a balanced mix of intangible and tangible assets.
Goodwill has declined from $3.7B in 2025Q3 to $3.1B in 2026Q2, possibly due to impairments or divestitures, which may indicate a reassessment of acquisition values. PPE has remained stable around $4.5-4.7B, consistent with the low capital intensity (capex ~2.4% of revenue) noted in the cash flow analysis. The asset mix suggests a mature business with limited expansion, but the stability of PPE implies disciplined investment.
Negative Equity Looms
According to the latest balance sheet data, CL's retained earnings stand at $27.1B, yet total equity is only $236M, implying that massive share repurchases have nearly wiped out the equity cushion.
The retained earnings balance is substantial, but the equity base is minuscule because the company has spent heavily on buybacks, as evidenced by the prior cash flow analysis showing dividends and buybacks totaling $753M in 2026Q2 alone. This suggests that the company is returning capital to shareholders at a pace that exceeds earnings retention, which may lead to negative equity if the trend continues. While negative equity is not uncommon for mature staples, it reduces financial flexibility and increases sensitivity to earnings shocks.
Liquidity Buffer Thin but Stable
As reported in financial statements, CL's current ratio improved to 1.03 in 2026Q2 from 0.89 a year earlier, with cash of $1.4B, providing a modest buffer against short-term obligations.
The current ratio has hovered near 1.0 over the past year, indicating that current assets barely cover current liabilities, which is typical for a company with efficient working capital management. Cash of $1.4B is relatively stable, and with operating cash flow averaging strong levels (as per prior analysis), the company appears able to meet its short-term obligations. However, the thin liquidity buffer leaves little room for unexpected shocks, especially given the high debt load.
Hidden Risk in Negative Equity
The most non-obvious risk is that CL's equity is nearly zero, which could trigger debt covenant violations or restrict access to capital markets, despite the company's stable cash flows.
While the company's cash flow generation is robust, the near-zero equity base means that any further buybacks or losses could push equity negative, potentially breaching debt covenants that require a minimum equity level. This could force the company to reduce shareholder returns or raise equity, which would be dilutive. Investors should monitor the equity trajectory and any covenant disclosures in the footnotes, as this risk is not apparent from headline profitability metrics.